Sept. 13, 2022– President Biden’s call for a “moonshot” campaign to cut the death rate from cancer by at least 50% over the next 25 years focuses renewed attention on ensuring access to affordable cancer care for patients living with low incomes and those who live in often-underserved rural communities across the country. The 340B drug pricing program plays a vital role in … [Read more...]
Faces of 340B: Community Pharmacy Partnerships Aid in the Cancer Care Cause
April 22, 2022 – A bell rings and a round of applause is heard. A patient is marking the end of their cancer treatments at St. Anthony Regional Hospital in Carroll, Iowa. The patient knows the chemotherapy and radiation treatments they received from the St. Anthony Regional Cancer Center enabled them to reach this special day. What they may not realize is that the hospital’s … [Read more...]
340B Is a Key Element of the Mission Against Breast Cancer
Oct. 22, 2021– Each October, national organizations aim to make more Americans aware of what they can do to prevent and treat breast cancer as well as support people whose lives have been affected by the disease. Breast Cancer Awareness Month also is a time to look at how the 340B drug pricing program can help expand prevention and treatment efforts. Screenings Are … [Read more...]
MedPAC Report Addresses Key 340B Questions
March 18, 2020– A new report from a respected, independent congressional advisory panel sheds light on several of the key questions surrounding the 340B drug pricing program. In its March 2020 report to Congress, the Medicare Payment Advisory Commission (MedPAC) examined whether participation in the 340B program leads to higher drug spending for Medicare patients with five … [Read more...]
Does 340B Really Drive Up the Cost Of Cancer Care?
Feb. 8, 2018— Academic experts continue to question claims that the 340B drug discount program is the cause of consolidations of private physician practices and community-based hospitals. They argue the trend toward consolidation is much more complex and due to a series of factors, including changes in reimbursement policies. In the Feb. 8 issue of Forbes magazine, Duke … [Read more...]